Category: New products
-
Compound Found to Prevent Asthma Inflammation
A research team in Cincinnati discovered a small-molecule drug compound that in lab mice prevents cells in the lungs from becoming inflamed, as occurs in asthma attacks.
-
Vaccine R&D Underway to Protect Against Animal Microbes
Research is underway in the U.K. on development of new vaccines to protect humans against zoonotic diseases, infectious diseases originating in animals.
-
Nanoparticles Boost T-Cells to Fight Leukemia
A cancer research lab designed a process to treat leukemia by reprogramming cells in the immune system with genes on nanoscale biodegradable particles.
-
Crispr-Based Diagnostics System Designed
A bioengineering team from Harvard University and Massachusetts Institute of Technology designed simple, inexpensive diagnostics tools to detect infectious diseases, based on Crispr, an emerging genome-editing technology.
-
Corn, Shellfish Ingredients Enable DNA Vaccine Pills
Biomaterials researchers discovered substances from corn and shellfish can package genetic material to pass through the digestive system, making possible vaccines as pills rather than injections.
-
NIH Funds Drug-Resistant Malaria Therapy Trial
An agency of National Institutes of Health is funding a clinical trial of a new malaria drug engineered to overcome resistance developed to earlier treatments.
-
Phones, Algorithms Boost Adherence to Stroke Meds
Results from a clinical trial show a smartphone-based remote monitoring program helps stroke patients stay on their blood clot medications and improve their health.
-
Student Project Leads to Medical Device Start-Up
A group of engineering and business students developing an imaging device that quickly finds veins for blood draws is starting a company to take the device to market.
-
Engineered Bacteria Designed to Detect Gut Inflammation
A bioengineering team at Rice University developed a genetically modified form of bacteria that in lab mice detects inflammatory diseases in the gut.
-
Antibody Shows Promise Against Marburg Virus Infections
Tests with lab animals show an experimental synthetic antibody protects against deadly Marburg and Ravn viruses as long as 5 days following infections.